These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa. Carme B; Peguet C; Nevez G Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484 [TBL] [Abstract][Full Text] [Related]
4. Antimalarial chemoprophylaxis for west Africa. Basco LK; Le Bras J Lancet; 1993 Apr; 341(8849):902-3. PubMed ID: 8096609 [No Abstract] [Full Text] [Related]
5. Compliance and tolerability of mefloquine and chloroquine plus proguanil for long-term malaria chemoprophylaxis in groups at particular risk (the military). Peragallo MS; Sabatinelli G; Sarnicola G Trans R Soc Trop Med Hyg; 1999; 93(1):73-7. PubMed ID: 10492796 [TBL] [Abstract][Full Text] [Related]
6. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574 [TBL] [Abstract][Full Text] [Related]
7. The effect of chemoprophylaxis on the timing of onset of falciparum malaria. Reyburn H; Behrens RH; Warhurst D; Bradley D Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928 [TBL] [Abstract][Full Text] [Related]
8. Long-term malaria prophylaxis with weekly mefloquine. Lobel HO; Miani M; Eng T; Bernard KW; Hightower AW; Campbell CC Lancet; 1993 Apr; 341(8849):848-51. PubMed ID: 8096560 [TBL] [Abstract][Full Text] [Related]
11. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849 [TBL] [Abstract][Full Text] [Related]
12. Trends in malaria chemoprophylaxis prescription in South Africa 1994 to 2000. Leggat PA; Dürrheim DN; Blumberg L J Travel Med; 2002; 9(6):318-21. PubMed ID: 12962587 [TBL] [Abstract][Full Text] [Related]
13. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
16. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa. Wetsteyn JC; de Geus A BMJ; 1993 Oct; 307(6911):1041-3. PubMed ID: 8123120 [TBL] [Abstract][Full Text] [Related]
17. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial. Croft AM; Clayton TC; World MJ Trans R Soc Trop Med Hyg; 1997; 91(2):199-203. PubMed ID: 9196769 [TBL] [Abstract][Full Text] [Related]
19. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. Barrett PJ; Emmins PD; Clarke PD; Bradley DJ BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa. Fontanet AL; Houzé S; Keundjian A; Schiemann R; Ralaimazava P; Durand R; Cha O; Coulaud JP; Le Bras J; Bouchaud O Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):91-100. PubMed ID: 15607335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]